Table 7.
Effect of NeoSTX on serum biochemical parameters at 17 weeks (n = 5 per group).
| Control | Solvent | NeoSTX 1 μg/kg | NeoSTX 3 μg/kg | NeoSTX 6 μg/kg | |
|---|---|---|---|---|---|
| Glucose (mg/dL) | 334.7 ± 61.3 | 352.5 ± 45.67 | 297.5 ± 53.2323 | 335.8 ± 52.32 | 325.8 ± 52.46 |
| Ureic Nitrogen (mg/dL) | 16.3 ± 1.73 | 17.6 ± 1.49 | 15.9 ± 1.57 | 18.4 ± 2.1 | 18.1 ± 1.6 |
| Ureic acid (mg/dL) | 0.92 ± 0.42 | 1.22 ± 0.54 | 0.96 ± 0.51 | 1.10 ± 0.3 | 1.5 ± 0.57 |
| Total Protein (g/dL) | 6.32 ± 0.24 | 6.36 ± 0.26 | 6.42 ± 0.26 | 6.46 ± 0.5 | 6.35 ± 0.47 |
| Albumin (g/dL) | 3.30 ± 0.19 | 3.24 ± 0.17 | 3.28 ± 0.19 | 3.32 ± 0.22 | 3.29 ± 0.20 |
| Total Cholesterol (mg/dL) | 59.3 ± 7.38 | 62.6 ± 6.52 | 64.4 ± 6.35 | 63.8 ± 5.8 | 62.8 ± 6.18 |
| HDL (mg/dL) | 38.6 ± 4.52 | 43.1 ± 4.43 | 42.9 ± 5.36 | 43.5 ± 6.10 | 41.8 ± 6.12 |
| LDL (mg/dL) | 10.53 ± 4.34 | 12.58 ± 6.33 | 10.5 ± 5.42 | 11.34 ± 4.87 | 10.54 ± 4.90 |
| Triglycerides (mg/dL) | 93.5 ± 23.4 | 102.3 ± 36.4 | 90.6 ± 22.4 | 76.8 ± 25.66 | 105.2 ± 32.10 |
| LDH (U/L) | 2525.4 ± 665.50 | 2248.6 ± 735.42 | 2160.8 ± 460.76 | 2650.2 ± 643.55 | 2540.9 ± 580.32 |
| Creatinine (mg/dL) | 0.53 ± 0.05 | 0.54 ± 0.04 | 0.52 ± 0.04 | 0.51 ± 0.05 | 0.53 ± 0.05 |
| Total Bilirubin (mg/dL) | 0.11 ± 0.02 | 0.12 ± 0.01 | 0.11 ± 0.01 | 0.10 ± 0.03 | 0.12 ± 0.03 |
| Direct Bilirubin (mg/dL) | 0.02 ± 0.02 | 0.03 ± 0.02 | 0.02 ± 0.03 | 0.01 ± 0.02 | 0.03 ± 0.02 |
| Alkaline Phosphatase (U/L) | 226.8 ± 48.37 | 242.9 ± 54.35 | 248.9 ± 42.52 | 225.2 ± 45.55 | 235.6 ± 49.76 |
| GGT (U/L) | 7.2 ± 1.51 | 7.3 ± 1.22 | 7.4 ± 0.91 | 7.8 ± 2.45 | 7.4 ± 1.73 |
| SGOT (UI/dL) | 89.5 ± 11.55 | 91.6 ± 11.83 | 96.4 ± 10.65 | 88.9 ± 10.88 | 95.8 ± 12.45 |
| SGPT (UI/dL) | 65.4 ± 5.87 | 65.2 ± 4.22 | 62.3 ± 4.55 | 68.2 ± 5.28 | 70.1 ± 8.77 |